We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Veeva Systems (VEEV) Beats Stock Market Upswing: What Investors Need to Know
Read MoreHide Full Article
In the latest close session, Veeva Systems (VEEV - Free Report) was up +1.83% at $291.25. The stock's change was more than the S&P 500's daily gain of 0.07%. Meanwhile, the Dow experienced a drop of 0.7%, and the technology-dominated Nasdaq saw an increase of 0.18%.
Heading into today, shares of the provider of cloud-based software services for the life sciences industry had gained 2.33% over the past month, lagging the Medical sector's gain of 2.39% and the S&P 500's gain of 5.71%.
The upcoming earnings release of Veeva Systems will be of great interest to investors. The company's upcoming EPS is projected at $1.9, signifying a 17.28% increase compared to the same quarter of the previous year. Meanwhile, the latest consensus estimate predicts the revenue to be $767.61 million, indicating a 13.52% increase compared to the same quarter of the previous year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $7.64 per share and a revenue of $3.1 billion, signifying shifts of +15.76% and +12.78%, respectively, from the last year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Veeva Systems. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Veeva Systems is currently a Zacks Rank #2 (Buy).
Looking at its valuation, Veeva Systems is holding a Forward P/E ratio of 37.42. This denotes a premium relative to the industry average Forward P/E of 31.
Also, we should mention that VEEV has a PEG ratio of 1.61. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As of the close of trade yesterday, the Medical Info Systems industry held an average PEG ratio of 3.25.
The Medical Info Systems industry is part of the Medical sector. With its current Zacks Industry Rank of 73, this industry ranks in the top 30% of all industries, numbering over 250.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Veeva Systems (VEEV) Beats Stock Market Upswing: What Investors Need to Know
In the latest close session, Veeva Systems (VEEV - Free Report) was up +1.83% at $291.25. The stock's change was more than the S&P 500's daily gain of 0.07%. Meanwhile, the Dow experienced a drop of 0.7%, and the technology-dominated Nasdaq saw an increase of 0.18%.
Heading into today, shares of the provider of cloud-based software services for the life sciences industry had gained 2.33% over the past month, lagging the Medical sector's gain of 2.39% and the S&P 500's gain of 5.71%.
The upcoming earnings release of Veeva Systems will be of great interest to investors. The company's upcoming EPS is projected at $1.9, signifying a 17.28% increase compared to the same quarter of the previous year. Meanwhile, the latest consensus estimate predicts the revenue to be $767.61 million, indicating a 13.52% increase compared to the same quarter of the previous year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $7.64 per share and a revenue of $3.1 billion, signifying shifts of +15.76% and +12.78%, respectively, from the last year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Veeva Systems. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Veeva Systems is currently a Zacks Rank #2 (Buy).
Looking at its valuation, Veeva Systems is holding a Forward P/E ratio of 37.42. This denotes a premium relative to the industry average Forward P/E of 31.
Also, we should mention that VEEV has a PEG ratio of 1.61. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As of the close of trade yesterday, the Medical Info Systems industry held an average PEG ratio of 3.25.
The Medical Info Systems industry is part of the Medical sector. With its current Zacks Industry Rank of 73, this industry ranks in the top 30% of all industries, numbering over 250.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.